High Court rules against regulator in pharma transparency case

Royal Courts of Justice

A High Court judge has concluded that the Health Research Authority acted unlawfully in applying new transparency rules on pharmaceutical companies carrying out clinical trials.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here